384 related articles for article (PubMed ID: 1079475)
1. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
Cass CE; Tan TH; Selner M
Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
Cass CE; Au-Yeung TH
Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
5. Effect of an adenosine deaminase inhibitor on the uptake and metabolism of arabinosyl adenine (Vidarabine) by intact human erythrocytes.
Chang T; Glazko AJ
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):127-40. PubMed ID: 935646
[TBL] [Abstract][Full Text] [Related]
6. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes.
Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O
Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516
[TBL] [Abstract][Full Text] [Related]
7. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
8. The utilization of nucleotides by animal cells.
Cohen SS; Plunkett W
Ann N Y Acad Sci; 1975 Aug; 255():269-86. PubMed ID: 1059361
[TBL] [Abstract][Full Text] [Related]
9. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
Plunkett W; Cohen SS
Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
[No Abstract] [Full Text] [Related]
10. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
LePage GA; Worth LS; Kimball AP
Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.
Lee SH; Caron N; Kimball AP
Cancer Res; 1977 Jul; 37(7 Pt 1):1953-5. PubMed ID: 861931
[TBL] [Abstract][Full Text] [Related]
12. [Action of deoxyadenosine on nucleic acid synthesis by tumor cells in the presence of a deaminase inhibitor].
Vornovitskaia GI; Ioannesiants IA; Borzenko BG; Shapot VS
Vopr Med Khim; 1975; 21(2):192-5. PubMed ID: 166514
[TBL] [Abstract][Full Text] [Related]
13. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
Carson DA; Seegmiller JE
J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
[TBL] [Abstract][Full Text] [Related]
14. Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse.
Ho DH; Pincus C; Carter CJ; Benjamin RS; Freireich EJ; Bodey GP
Cancer Treat Rep; 1980; 64(4-5):629-33. PubMed ID: 6968622
[TBL] [Abstract][Full Text] [Related]
15. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
Smith SH; Shipman C; Drach JC
Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine.
Helland S; Ueland PM
Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.
Suling WJ; Rice LS; Shannon WM
Cancer Treat Rep; 1978 Mar; 62(3):369-73. PubMed ID: 647695
[No Abstract] [Full Text] [Related]
18. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained.
Overgaard-Hansen K; Klenow H
J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adenosine deaminase and nucleoside transport. Utility in a model of homograft cardiac valve preimplantation processing.
Abd-Elfattah AS; Messier RH; Domkowski PW; Jones JL; Aly HM; Crescenzo DG; Wallace RB; Hopkins RA
J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1095-105. PubMed ID: 8501937
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
Sato A; Montgomery JA; Cory JG
Cancer Res; 1984 Aug; 44(8):3286-90. PubMed ID: 6611198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]